Literature DB >> 6289779

Ultrastructural study on type C virus particles in a human cord T-cell line established by co-cultivation with adult T-cell leukemia cells.

Y Ohtsuki, T Akagi, K Takahashi, I Miyoshi.   

Abstract

Entities:  

Mesh：

Year:  1982        PMID： 6289779     DOI： 10.1007/bf01341729

Source DB:  PubMed          Journal:  Arch Virol        ISSN： 0304-8608            Impact factor:   2.574


× No keyword cloud information.
  9 in total

1.  Comparative studies of type C, type B, and M-PM oncornaviruses.

Authors:  L Dmochowski; J M Bowen; B Myers; E S Priori; M F Miller; G Seman; J C Chan; M L Dodson; M Scanlon; Y Ohtsuki; H Yoshida
Journal:  Bibl Haematol       Date:  1975-10

2.  Intracisternal A particles and C particles.

Authors:  A J Dalton; S E Stewart
Journal:  Science       Date:  1972-04-21       Impact factor: 47.728

3.  Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells.

Authors:  I Miyoshi; I Kubonishi; S Yoshimoto; T Akagi; Y Ohtsuki; Y Shiraishi; K Nagata; Y Hinuma
Journal:  Nature       Date:  1981-12-24       Impact factor: 49.962

4.  Transformation of normal human cord lymphocytes by co-cultivation with a lethally irradiated human T-cell line carrying type C virus particles.

Authors:  I Miyoshi; S Yoshimoto; I Kubonishi; H Taguchi; Y Shiraishi; Y Ohtsuki; T Akagi
Journal:  Gan       Date:  1981-12

5.  Suggestions for the classification of oncogenic RNA viruses.

Authors: 
Journal:  J Natl Cancer Inst       Date:  1966-09       Impact factor: 13.506

6.  Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease.

Authors:  M Yoshida; I Miyoshi; Y Hinuma
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

7.  The morphology of murine oncornaviruses following different methods of preparation for electron microscopy.

Authors:  N H Sarkar; W J Manthey; J B Sheffield
Journal:  Cancer Res       Date:  1975-03       Impact factor: 12.701

8.  Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera.

Authors:  Y Hinuma; K Nagata; M Hanaoka; M Nakai; T Matsumoto; K I Kinoshita; S Shirakawa; I Miyoshi
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

9.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205
  9 in total
  5 in total

1.  Immunocytochemical and ultrastructural characterization of human T-lymphotropic virus type I (HTLV-I)-producing rabbit lymphoid cell lines.

Authors:  Y Ohtsuki; I Miyoshi; T Oka; K Hayashi; K Takahashi; M Furihata; J Iwata; T Takeuchi; H Sonobe
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

2.  Suppressive effects of interferons on the production and release of human T-lymphotropic virus type-I (HTLV-I).

Authors:  T Oka; Y Ohtsuki; H Sonobe; M Furihata; I Miyoshi
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

3.  Fine structure of human- and monkey-derived type C virus particles in monkey lymphoid cell lines expressing adult T-cell leukemia-associated antigens. Brief report.

Authors:  Y Ohtsuki; I Miyoshi; S Yoshimoto; K Takahashi; T Akagi
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

4.  Detection of antibodies to adult T-cell leukemia (ATL)-associated virus in ATL patients' sera by immunoelectron microscopy.

Authors:  Y Ohtsuki; T Akagi; K Takahashi; I Miyoshi
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

5.  Predicting and Designing Epitope Ensemble Vaccines against HTLV-1.

Authors:  Saruar Alam; Md Kamrul Hasan; Omar Hamza Bin Manjur; Akib Mahmud Khan; Zinat Sharmin; Mahmud Arif Pavel; Md Faruk Hossain
Journal:  J Integr Bioinform       Date:  2020-01-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.